Torisel FDA Approval History
FDA Approved: Yes (First approved May 30, 2007)
Brand name: Torisel
Generic name: temsirolimus
Dosage form: Injection
Company: Wyeth Pharmaceuticals, Inc.
Treatment for: Renal Cell Carcinoma
Torisel (temsirolimus), an inhibitor of mTOR kinase, is an antineoplastic agent indicated for the treatment of patients with advanced renal cell carcinoma.
Development Timeline for Torisel
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.